Switzerland


Pharmaceutical giant threatens to drag Government before corporate tribunal
Novartis battle against Colombian Government highlights the threats to public health posed by the outrageous investor-state dispute settlement regime and bad “trade” deals.
Switzerland wants stricter intellectual property rules in India that could harm generic drug makers
Switzerland is pushing for tighter patent protection, data exclusivity and dropping compulsory licencing under a new free trade agreement.
Leaked document: Note by Switzerland on India EFTA TEPA IP Chapter
In this note, Switzerland is proposing that India agree to broader patentable subject matter, particularly as regards biologic products.
The (partial) dissent in Philip Morris: Gary Born vs. the constitution of Uruguay
A dissent sends the message: beware, if one other arbitrator had gone the way that Born did, we would have won.
Costa Rica wins international arbitration against Zeta Gas
The ICSID Arbitral Tribunal has ruled that the Costa Rican government did not cause damage to the company of Swiss capital, Gas Nacional Zeta.
UK agrees ‘immediate’ post-Brexit talks with US, leaving EU high and dry
US President Donald Trump has agreed to start immediate trade talks with Britain. Switzerland took a similar course of action.
China and Switzerland vow to upgrade FTA
Chinese President vowed to upgrade sections of the FTA and encourage further innovation, as well as expand the scale of cooperation in the finance and insurance fields.
Investigation: As Colombia pushes for cancer drug price-cut and considers compulsory licensing, Novartis responds with quiet filing of an investment treaty notice
Novartis lodged a formal notice of dispute under the Switzerland-Colombia BIT.
First season in Switzerland without occupation tomatoes?
From this winter on, Swiss supermarkets will probably, for the first time, no longer sell tomatoes from occupied Western Sahara.
TiSA - second revised Swiss offer (October 2016)
Released by the Government of Switzerland